No intervention
OtherNo intervention
NCT Number: NCT05560633
1. Learning curve of ms-Tram and DIEP breast reconstructions surgery are important to guide the training of new surgeon. 2. Buried flap post operative monitoring without implantable doppler was seldom studied, a validated protocol reported. 3. The complication rates of the flap and oncological safety were studied.
Looking for future studies?
Notify Me18 year and older
Female
Observational
Operative time and complication rate are employed to analysis the learning curve of the ms-Tram and DIEP surgery,which is meaningful for the new microsurgeon training.
Buried flap without the implatable doppler is very common condition all over the world, and the complication rate was evaluated as evidence of reliable of the validated monitoring protocol.
Complication rates were considered as different before and after the platue of the learning curve. Within the study of the learning curve, complication rates were reported.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
No intervention
Time frame: Through study completion, and average of 2.5 year
The rate of ms-tram and diep flap were removed from the patients
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Other
The Feasibility of Nipple-sparing Mastectomy in Combined With Abdominal Free Flap Breast Reconstruction Without Skin Paddles for Flap Monitoring: a Single-center Experience
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05150652
Breast Cancer, Breast Carcinoma
Lexington, Kentucky, United States
View Trial DetailsNCT00469339
Breast Cancer, Breast Diseases
Houston, Texas, United States
View Trial DetailsNCT05838417
Breast Cancer, Breast Diseases
Aurora, Colorado, United States
View Trial DetailsNCT00040222
Adnexal Diseases, BRCA1-associate Malignancies
Bethesda, Maryland, United States
View Trial Details